This afternoon, the Government of the Hong Kong Special Administrative Region welcomed the passage of the Stamp Duty Legislation (Miscellaneous Amendments) Bill 2024 by the Legislative Council, which exempted the transfer of shares or units of real estate investment trusts and the securities distribution business of option makers, and revised the stamp duty collection arrangements under the paperless securities market system in Hong Kong.Yesterday, the market opened higher and went lower, and the shape looked very poor. Many friends today estimated that they were prepared to continue the downward adjustment, but in fact, the market was still relatively stable today. Although the increase was not large, there was no sharp diving in the plate, as if it were held by a hand. Yes, it is really held up now, because it is now in a state of high control, so everyone has seen the recent trend. Excluding yesterday, it is still relatively stable. How many investors expect the market to fall down and get on the bus, but it just won't come down. The 3150 gap below is counted this week, and it has not been replenished for 11 weeks. It cannot be said that the market is not strong. So can the market continue to rise tomorrow? Let's make a detailed analysis and give you a reference.Federal Reserve's December Outlook
Shanghai stock exchange recently releasedFederal Reserve's December Outlook
Dezhe Medicine is a listed company in science and technology innovation board, and it is an innovation-driven biomedical company with global competitiveness. Therefore, its refinancing has been approved by the Shanghai Stock Exchange, which also shows that the supervision is tolerant of companies with core technology and hard power. Although it may not be ideal financially for the time being, it has broad prospects and great imagination, which is worthy of support.A major breakthrough! Quantum technology frenzy strikesDizhe Pharmaceutical announced that the company's private placement plan has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of the unprofitable enterprise on the Shanghai Stock Exchange has been approved since the release of "Keba Article".
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
Strategy guide
12-13
Strategy guide
12-13